After using its stem cell technology to discover drugs, iPierian Inc. and its backers are hoping that splitting into two companies and infusing them with a collective $30 million will bring an Alzheimer's disease therapy and autoimmune drug to market faster.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/09/stem-cells-alzheimer-ipierian-true-north.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_national+%28Bizjournals+National+Feed%29
http://www.bizjournals.com/sanfrancisco/blog/biotech/2013/09/stem-cells-alzheimer-ipierian-true-north.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bizj_national+%28Bizjournals+National+Feed%29
No comments:
Post a Comment